The Next 5 Years in Emerging Biotech
Summary: Experts explain the investment interest by pointing to several trends, spanning new therapeutics, the scale-up of new modalities, and ongoing innovation. But what will it take for these breakthroughs to realize their potential in the clinic and deliver effective treatments to patients? The successful biotechs of tomorrow require robust analytical methods and manufacturing processes, built either in house or through a strong partnership with a contract development and manufacturing organization (CDMO), to map a solid path to market.
Over the next five years, emerging biotechs are poised to develop revolutionary therapeutics and new modalities that could turn healthcare on its head. The deep investment into this space ultimately reflects a sense of hope that transcends revenues and industry growth: At its heart, that hope is for the patients whose lives could be changed for the better by new, more effective therapeutic advances.